--- title: "Sepsis Patients With Fevers Get Antibiotics Fast; Patients With Stomach Symptoms Wait" description: "A 29,647-patient Michigan study ties presenting symptoms to how quickly sepsis treatment starts" author: "Nate Ledger" published: 2026-09-28T20:44:47.756Z modified: 2026-09-28T21:21:40Z url: https://rews.cc/a/sepsis-patients-with-fevers-get-antibiotics-fast-patients-wi-c2bb41 language: en tags: ["sepsis", "antibiotics", "health", "jama", "fever"] publisher: "Rews (https://rews.cc)" --- # Sepsis Patients With Fevers Get Antibiotics Fast; Patients With Stomach Symptoms Wait *A 29,647-patient Michigan study ties presenting symptoms to how quickly sepsis treatment starts* By Nate Ledger · September 28, 2026 · https://rews.cc/a/sepsis-patients-with-fevers-get-antibiotics-fast-patients-wi-c2bb41 ## In brief - A JAMA Network Open study of 29,647 sepsis patients at 67 Michigan hospitals found symptoms affect how fast antibiotics arrive - Prehospital fever raised the odds of timely antibiotics; gastrointestinal symptoms lowered them - Timely antibiotics were associated with 18.9% versus 21.0% 30-day mortality, an adjusted gap of 2.10 percentage points - CDC and FDA are investigating 13 E. coli cases in nine states linked to Graziers raw-milk cheeses; three patients developed HUS - US and EU objections blocked UN adoption of a declaration endorsing the WHO Pandemic Agreement Sepsis is what doctors call it when the body’s response to an infection starts damaging its own organs, and it is a leading cause of in-hospital death in the United States. The treatment playbook is well established: get antibiotics into the patient fast. Guidelines treat three hours from hospital presentation as the target when septic shock is absent, and earlier work has shown that patient and hospital characteristics influence whether that target gets hit. What had not been studied much is something more basic: does it matter what the patient’s symptoms look like when they walk in the door? It matters quite a bit, according to a study published in JAMA Network Open and reported by CIDRAP. Researchers looked at 29,647 adults with presumed community-onset bacterial sepsis at 67 hospitals in the Michigan Hospital Medicine Safety Consortium-Sepsis Initiative. The median patient was 71, and 21,957 of them, or 74%, received timely antibiotics. “This is an important gap, as clinicians rely on presenting symptoms to diagnose infection and make decisions about antibiotic initiation,” the authors wrote of the question. The pattern that emerged is almost intuitive once you see it. Patients who arrived with a fever they’d had before reaching the hospital — the classic, unmistakable sign of infection — were more likely to get antibiotics on time, with adjusted odds ratios of 1.34 for patients with hypotension and 1.26 for those without. Patients whose presentation was gastrointestinal — nausea, vomiting, abdominal complaints — were less likely, with adjusted odds ratios of 0.84 and 0.80 respectively. Among patients without hypotension, urinary symptoms nudged the odds up (aOR, 1.13) and respiratory symptoms nudged them down (aOR, 0.91). In other words: the more sepsis looked like the textbook version of sepsis, the faster it got treated; the more it looked like a bad stomach bug, the slower the clock ran. The stakes are visible in the mortality numbers. Across the whole cohort, timely antibiotics were associated with lower 30-day mortality, 18.9% versus 21.0%, an adjusted absolute difference of –2.10 percentage points. Applied across 29,647 patients, that gap represents on the order of 600 lives, though the study design shows association rather than proof of causation. The authors’ conclusion was aimed squarely at triage: “These findings suggest that proactive screening for sepsis among patients with less obvious clinical presentations may promote timely recognition and treatment.” ## Raw-milk cheese, multistate E. coli The CDC and FDA are investigating a multistate outbreak of E. coli infections tied to Graziers raw (unpasteurized) milk cheeses sold by Sierra Nevada Cheese Company of Willows, California, CIDRAP reports. So far investigators have identified 13 cases across nine states, with eight patients hospitalized and three developing hemolytic uremic syndrome, a severe complication that can cause acute kidney failure. No deaths have been reported, and more than half of the case patients are under 5 years old. California and Nevada have three cases each, with single cases in Oregon, Utah, Colorado, Michigan, Kentucky, Georgia and Tennessee, and illness-onset dates running from July 7 to August 26. Both agencies expect the official count to understate reality. “The true number of sick people in this outbreak is likely much higher than the number reported, and the outbreak may not be limited to the states with known illnesses,” the CDC said, because “many people recover without medical care and are not tested for E. coli.” The FDA’s consumer advice reflects the awkward fact that cheese sits around: “This product has a long shelf life. Check your refrigerators and freezers for the recalled raw milk cheeses and throw them away.” Both agencies urged consumers to pick pasteurized dairy over raw, especially for children under 5. ## The pandemic pact that wasn’t Meanwhile, at the United Nations’ second High-Level Meeting on pandemic prevention, preparedness and response, the United States and the European Union blocked member states from adopting a declaration endorsing the WHO Pandemic Agreement — the framework for international coordination that has been in the works since 2021 and was adopted by the World Health Assembly in May 2025, according to CIDRAP. The declaration also pushed for finalizing the agreement’s Pathogen Access and Benefit-Sharing System, the annex meant to govern rapid sharing of dangerous pathogens so that diagnostics, treatments and vaccines can be developed quickly. “The Pathogen Access and Benefit Sharing System, under negotiation, is critical to unlocking the full potential of the WHO Pandemic Agreement. There is no time to waste,” UN Deputy Secretary-General Amina Mohammed said. The objections came from different directions. CDC Director Erica Schwartz, MD, MPH, JD, told the meeting that unresolved problems remain: “Whether it is the inclusion of divisive ideologies that lack definitional consensus or references to an unfinished negotiation on pathogen access and benefit sharing in an agreement that failed to achieve international consensus, the United States is not in a position to support this text,” she said, according to Health Policy Watch. The EU’s statement said the declaration offers useful elements but “also contains setbacks toward our crucial, shared goal: a safer, healthier world for all” — its red lines included a requirement that technology transfer remain “voluntary and on mutually agreed terms.” The declaration is expected to come back before a future UN General Assembly meeting.